Antibiotics and Vaccine Immune Responses Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Vaccine Response Impaired
Interventions
BIOLOGICAL

BCG vaccine

0.1ml injected intradermally over the distal insertion of the deltoid muscle onto the humerus

BIOLOGICAL

Yellow Fever vaccine

0.5ml injected subcutaneously

DRUG

Vancomycin Oral Capsule

500mg every 6 hours for 3 days

DRUG

Neomycin Oral Product

1000mg every 6 hours for 3 days

Trial Locations (1)

5000

RECRUITING

South Australian Health and Medical Research Institute, Adelaide

All Listed Sponsors
collaborator

Royal Adelaide Hospital

OTHER

collaborator

Flinders University

OTHER

collaborator

University of Sydney

OTHER

collaborator

Telethon Kids Institute

OTHER

collaborator

Centenary Institute of Cancer Medicine and Cell Biology

UNKNOWN

lead

South Australian Health and Medical Research Institute

OTHER